At the news
? BULLISHIMPACT 4/10 CLUSTER filed Aug 6, 2026 at 11:26 ET
Two Pfizer directors (Blaylock and Buckley) made open-market purchases totaling ~$1.96M on the same day the company's SVP & Controller sold $83K. The director buys follow Pfizer's Q2 2026 earnings beat (reported Aug 4) where adjusted EPS of $0.77 beat consensus by 12.9% and revenue of $15.0B beat by 4.5%, alongside raised full-year guidance. The insider purchases suggest directors see value at the current ~$25.50/share level post-earnings, though the $1.96M total is tiny (0.0013% of Pfizer's $149B market cap) and the controller's small sale appears liquidity-driven.
- Two directors purchased 76.9K shares total for ~$1.96M on Aug 5, one day after Pfizer reported Q2 2026 earnings beat
- SVP & Controller Damico sold 3.3K shares for $83K on the same day (liquidity-sized, 0.00006% of market cap)
- Total insider buying of $1.96M is 0.0013% of Pfizer's $149.3B market cap, economically trivial
- Q2 2026 adjusted EPS of $0.77 beat consensus of $0.68 by 12.9%; revenue $15.0B beat $14.4B by 4.5%
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access